Cited by 193Lipoproteins and Cardiovascular HealthDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

The DOI matches its Crossref record; 104 of the 105 references it cites were found in a registry or an index.

Statins for the prevention of dementia

McGuinness, Bernadette, Craig, David, Bullock, Roger, Passmore, Peter·2009·Cochrane Database of Systematic Reviews

DOI 10.1002/14651858.cd003160.pub2

Open this paper in CoChat — free account

Abstract

Background This is an update of a Cochrane review first published in 2001. At that stage there was insufficient evidence to recommend statins for the prevention of Alzheimer's disease (AD). The scope of this review has been expanded to include all forms of dementia. Objectives To assess the effects of statins in the prevention of dementia. Search strategy The Specialized Register of the Cochrane Dementia and Cognitive Improvement Group, The Cochrane Library, MEDLINE, EMBASE, PsycINFO, CINAHL and LILACS were searched on 10 October 2007 using the terms statin*, lovastatin*, pravastatin*, simvastatin*, fluvastatin*, atorvastatin* and rosuvastatin*. The CDCIG Register contains records from many healthcare databases, SIGLE, LILACS as well as many trials databases and is updated regularly. Selection criteria Double-blind randomized placebo-controlled trials of statins in people at risk of AD and dementia. Data collection and analysis Two independent reviewers extracted and assessed data independently and agreement was reached after discussion. Adverse effects were noted. Main results Two trials were identified with 26,340 participants; HPS 2002 and PROSPER 2002. Age range was 40-82 years across the two studies, PROSPER 2002 included 5804 patients aged 70-82 years and HPS included 20,536 patients with 5806 at least 70 years old at study entry. Mean total cholesterol 5.9 mmol/l, LDL cholesterol 3.4 mmol/l at study entry with mean reduction in LDL cholesterol of 1.0 mmol/l in simvasta…

Integrity signals

Registry

Crossref · 10.1002/14651858.cd003160.pub2

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061894 · Cited by 2,887
Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.
Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,802
Statins and the risk of dementia
Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,764
CNS synaptogenesis promoted by glia-derived cholesterol
Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711

Flagged first, then by citations

Show all 105 references

1 of the 105 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Kuriyama, 1994, Low levels of serum apolipoprotein A I and A II in senile dementia, Japanese Journal of Psychiatry and Neurology, 48, 589
Refolo, 2001, A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of alzheimer's disease, Neurobiological Disorders, 8, 890

Sorted by citations

Items 101–193 of 193

Statin Use and Cognitive Function: Population-Based Observational Study with Long-Term Follow-Up
Joosten, H., Visser, S. T., van Eersel, M. E. A., Gansevoort, R. T., Bilo, H. J. G., Slaets, J. P. J., & Izaks, G. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115755 · Cited by 19
Association of Familial Hypercholesterolemia and Statin Use With Risk of Dementia in Norway
Mundal, L. J., Igland, J., Svendsen, K., Holven, K. B., Leren, T. P., & Retterstøl, K. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.7715 · Cited by 19
Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial
Cooper, S., CASLAKE, M. J., Evans, J. J., Hassiotis, A., Jahoda, A. J., McConnachie, A., Morrison, J., RING, H. A., Starr, J. M., Stiles, C., et al. (2014) · Trials · doi:10.1186/1745-6215-15-202 · Cited by 18
Simvastatin ameliorates cognitive impairments via inhibition of oxidative stress‑induced apoptosis of hippocampal cells through the ERK/AKT signaling pathway in a rat model of senile dementia
Liu, W., Zhao, Y. H., Zhang, X., & Ji, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8098 · Cited by 18
Dementia Risk Prediction: Are We There Yet?
Kamat, S. M., Kamat, A. S., & Grossberg, G. T. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2009.12.001 · Cited by 18
Sterol Lipid Metabolism in Down Syndrome Revisited: Down Syndrome Is Associated with a Selective Reduction in Serum Brassicasterol Levels
Tansley, G., Holmes, D. T., Lütjohann, D., Head, E., & Wellington, C. L. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/179318 · Cited by 19
Tratamento da demência: recomendações do Departamento Científico de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia
Caramelli, P., Marinho, V., Laks, J., Coletta, M. V. D., Stella, F., Camargos, E. F., Smid, J., Barbosa, B. J. A. P., Schilling, L. P., Balthazar, M. L. F., et al. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-s106pt · Cited by 35
The role of statins in amyotrophic lateral sclerosis: protective or not?
Al-Kuraishy, H. M., Jabir, M. S., Sulaiman, G. M., Mohammed, H. A., Al-Gareeb, A. I., Albuhadily, A. K., Jawad, S. F., Swelum, A. A., & Abomughaid, M. M. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1422912 · Cited by 17
Dose-Dependent Neuroprotection and Neurotoxicity of Simvastatin through Reduction of Farnesyl Pyrophosphate in Mice Treated with Intracerebroventricular Injection of Aβ 1-42
Jin, H., Chen, T., Li, G., Wang, C., Zhang, B., Cao, X., Sha, S., Wan, Q., & Chen, L. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150782 · Cited by 17
Overview and Current Status of Alzheimer’s Disease in Bangladesh
Rahman, M. R., Tajmim, A., Ali, M., & Sharif, M. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170012 · Cited by 21
Cognitive decline and T2DM—a disconnect in the evidence?
Strachan, M. W. J., & Price, J. F. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.38 · Cited by 16
Animal Research for Alzheimer Disease: Failures of Science and Ethics
Pippin, J. J., Cavanaugh, S. E., & Pistollato, F. (2019) · BRILL eBooks · doi:10.1163/9789004391192_021 · Cited by 16
A review of the potential therapeutic role of statins in the treatment of Alzheimer’s disease: current research and opinion
Benito‐León, J., Sánchez‐Ferro, Á., Mitchell, A. J., & Bermejo-Pareja (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s29105 · Cited by 15
Use of Statins and Risk of Dementia in Heart Failure: A Retrospective Cohort Study
Chitnis, A. S., Aparasu, R. R., Chen, H., Kunik, M. E., Schulz, P. E., & Johnson, M. L. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0295-4 · Cited by 15
Protective effects of carnosine on white matter damage induced by chronic cerebral hypoperfusion
Xu, A., Zhang, J., Ma, J., Bo, S., & Lu, X. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.191217 · Cited by 15
Recent Advancements in Neuroimaging‐Based Alzheimer's Disease Prediction Using Deep Learning Approaches in e‐Health: A Systematic Review
Zia‐ur‐Rehman, Awang, M. K., Ali, G., & Faheem, M. (2025) · Health Science Reports · doi:10.1002/hsr2.70802 · Cited by 17
Dietary modulators of statin efficacy in cardiovascular disease and cognition
Wang, H., Blumberg, J. B., Chen, C. ‐. O., Choi, S., Corcoran, M. P., Harris, S. S., Jacques, P. F., Kristo, A. S., Lai, C., Lamon‐Fava, S., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.04.001 · Cited by 14
Vascular cognitive impairment in dementia
Etherton‐Beer, C. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.06.004 · Cited by 13
Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors
Blasko, I., Kemmler, G., Jungwirth, S., Wichart, I., Weissgram, S., Jellinger, K. A., Tragl, K. H., & Fischer, P. A. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0599-4 · Cited by 13
Statins Reduces the Risk of Dementia in Patients with Late-Onset Depression: A Retrospective Cohort Study
Yang, Y.-H., Teng, H., Lai, Y., Li, S., Lin, C., Yang, A. C., Chan, H., Hsieh, Y., Lin, C.-F., Hsu, F.-Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137914 · Cited by 13
Recomendaciones en la prevención de reacciones adversas a medicamentos en personas mayores con demencia
Gómez‐Pavón, J., García, P. G., Román, I. F., Astiz, M. V., Rodríguez, J. G., Díaz, G. J., Fernández, N. P. M., Fernández, B., & Páez, J. M. J. (2010) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2009.10.002 · Cited by 15
Association between Previous Statin Use and Alzheimer’s Disease: A Nested Case-Control Study Using a National Health Screening Cohort
Kim, J. H., Lee, H. S., Wee, J. H., Kim, Y. H., Min, C., Yoo, D. M., & Choi, H. G. (2021) · Brain Sciences · doi:10.3390/brainsci11030396 · Cited by 11
Dementia and Alzheimer’s Disease
Barnes, D. E., López, O. L., & Yaffe, K. S. (2012) · Springer eBooks · doi:10.1007/978-94-007-5061-6_31 · Cited by 12
Treatment of vascular dementia Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
Brucki, S. M. D., Ferraz, A. C., de Freitas, G. R., Massaro, A. R., Radanovic, M., & Schultz, R. R. (2011) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642011dn05040005 · Cited by 10
Inflammation in Aging Processes
Finch, C. E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00012-9 · Cited by 10
Dementia
Sahathevan, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00018-5 · Cited by 12
Recent advances in the understanding of cognitive decline among the elderly
Gangolli, V. (2016) · Journal of Geriatric Mental Health · doi:10.4103/2348-9995.181914 · Cited by 9
Prevention Studies in Alzheimer’s Disease: Progress Towards the Development of New Therapeutics
Coley, N., Gallini, A., & Andrieu, S. (2015) · CNS Drugs · doi:10.1007/s40263-015-0256-9 · Cited by 11
Protective effect of carnosine on white matter damage in corpus striatum induced by chronic cerebral hypoperfusion
Ma, J., Yan, H., Wang, R., Bo, S., Lu, X., Zhang, J., & Xu, A. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.032 · Cited by 9
Predicting Alzheimer’s disease from cognitive footprints in mid and late life: How much can register data and machine learning help?
Luo, H., Hartikainen, S. A., Lin, J., Zhou, H., Tapiainen, V., & Tolppanen, A.-M. (2024) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2024.105540 · Cited by 8
Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions
Mohapatra, T. K., Nayak, R. R., Ganeshpurkar, A., Tiwari, P. K., & Kumar, D. (2025) · Ibrain · doi:10.1002/ibra.12197 · Cited by 8
Treatment of dementia: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
Caramelli, P., Marinho, V., Laks, J., Coletta, M. V. D., Stella, F., Camargos, E. F., Smid, J., Barbosa, B. J. A. P., Schilling, L. P., Balthazar, M. L. F., et al. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-s106en · Cited by 7
Drug development in dementia
Cunningham, E. L., & Passmore, A. P. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.04.013 · Cited by 7
Comparison between Complementary Dietary Treatment of Alzheimer Disease in Iranian Traditional Medicine and Modern Medicine.
Ahmadian-Attari, M. M., Mosaddegh, M., Kazemnejad, A., & Noorbala, A. A. (2013) · PubMed Central · Cited by 7
Les démences vasculaires
Bousser, M., & Chabriat, H. (2012) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31836-9 · Cited by 6
High-Throughput Clinical Trial Emulation with Real World Data and Machine Learning: A Case Study of Drug Repurposing for Alzheimer’s DiseasePreprint
Zang, C., Zhang, H., Xu, J., Zhang, H., Fouladvand, S., Havaldar, S., Cheng, F., Chen, K., Chen, Y., Glicksberg, B. S., et al. (2022) · medRxiv · doi:10.1101/2022.01.31.22270132 · Cited by 7
Prior Transient Ischemic Attack and Dementia After Subsequent Ischemic Stroke
Jacquin, A., Aboa-Éboulé, C., Rouaud, O., Osseby, G., Binquet, C., Durier, J., Moreau, T., Bonithon‐Kopp, C., Giroud, M., & Béjot, Y. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3182420b2c · Cited by 6
Dementia: Introduction, Epidemiology and Economic Impact
Werner, P., Savva, G. M., Maidment, I., Thyrian, J. R., & Fox, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-29492-6_16 · Cited by 7
Maintaining Cognitive Health in Elderly Women
Clifford, A., Yesufu-Udechuku, A., Edwards, L., Bandelow, S., & Hogervorst, E. (2009) · Aging Health · doi:10.2217/ahe.09.65 · Cited by 7
Systematic Review of Atorvastatin for the Treatment of Alzheimer's Disease
(2012) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-5374.2012.17.010 · Cited by 6
Exploring the Genetic Associations Between the Use of Statins and Alzheimer's Disease
Lee, J., Park, S., Kim, Y., Kim, H. M., & Oh, C. (2022) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2022.11.2.133 · Cited by 6
Characteristics of nursing home residents with late-stage dementia and pain
Rostad, H. M., Grov, E. K., Utne, I., & Halvorsrud, L. (2020) · Sykepleien Forskning · doi:10.4220/sykepleienf.2019.79184en · Cited by 8
Lifestyle Factors in the Prevention of Dementia: A Life Course Perspective
Qiu, C. (2014) · International perspectives on aging · doi:10.1007/978-3-319-06650-9_11 · Cited by 5
Somatic comorbidity and the progression of cognitive impairment
Bidzan, L., Jurek, P., Olech, M., Bidzan-Wiącek, M., Bidzan-Bluma, I., & Bidzan, M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1219449 · Cited by 6
Novel therapeutic approaches for targeting Alzheimer’s disease
Khodakiya, A., Chaudhary, S., Chaudhary, A., & Prajapati, B. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00020-0 · Cited by 5
Prevention of Cognitive Decline
Gutierrez, J., & Isaacson, R. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3106-0_12 · Cited by 5
Statins: An Update on Clinical Issues and Selected Adverse Effects
Gulum, A. H., & Hume, A. L. (2015) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2014.09.004 · Cited by 5
Statins - From Lipid-Lowering Benefits to Pleiotropic Effects
Liu, D. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1001540 · Cited by 4
Antioxidative strategies in cognitive impairment: a novel connection between biliverdin‐reductase and statins
Schneider, A., & Simons, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07548.x · Cited by 4
Prevention of dementia by ACE inhibitors and angiotensin receptor blockers - potential but not proven
Todd, S., McGuinness, B., & Passmore, A. P. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02490.x · Cited by 3
Self-citation
Prevention of cognitive decline: Lifestyle and other issues
George, C., Ummar, S., & Shaji, K. (2016) · Journal of Geriatric Mental Health · doi:10.4103/2348-9995.181917 · Cited by 3
Statin intolerance: diagnosis, treatment and alternative therapies
Naderi, S., & Cho, L. (2014) · Clinical Lipidology · doi:10.2217/clp.14.23 · Cited by 3
Cholesterol, lipoproteins, and cognitive impairment
Nash, D. T. (2009) · Journal of clinical lipidology · doi:10.1016/j.jacl.2009.10.002 · Cited by 3
Cognitive decline affects diabetic women
Perzyński, A., & Chmiel-Perzyńska, I. (2016) · Current Problems of Psychiatry · doi:10.1515/cpp-2016-0026 · Cited by 3
Is risk of Alzheimer disease a reason to use dietary supplements?
Dwyer, J. T., & Donoghue, M. D. T. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29498 · Cited by 3
Potential Therapeutic Effects of Statins in Alzheimer’s Disease
Mancuso, C., Head, E., Barone, E., Marzia Perluigi, A., Preziosi, P., & Butterfield, D. A. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_171 · Cited by 2
L’homéopathie ouvre de nouvelles voies de recherche dans la maladie d’Alzheimer
Billot, J.-P. (2012) · La Revue d Homéopathie · doi:10.1016/j.revhom.2012.07.001 · Cited by 2
Alzheimer's Disease, Cerebrovascular Disease and Dementia: Pathology, Risk Factors and Prevention; A Comprehensive Approach
Davey, D. A. (2016) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.100097 · Cited by 2
Kjennetegn ved sykehjemsbeboere med langtkommen demens og smerter
Rostad, H. M., Grov, E. K., Utne, I., & Halvorsrud, L. (2019) · Sykepleien Forskning · doi:10.4220/sykepleienf.2019.79184 · Cited by 7
Dementia and Systemic Disorders
Molano, J. R. V., & Kelley, B. J. (2013) · Wiley eBooks · doi:10.1002/9781118414019.ch4 · Cited by 2
EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY
Ушкалова, Е. А., Tkacheva, O. N., Рунихина, Н. К., Чухарева, Н. А., & Bevz, A. Y. (2016) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2016-12-3-351-358 · Cited by 1
Questions to the PBAC: Gabapentin
Shenfield, G. M. (2013) · Australian Prescriber · doi:10.18773/austprescr.2013.040 · Cited by 1
Novel Pharmacological Approach to the Treatment of Alzheimer’s Disease
-, M. S. D., & -, P. T. J. (2022) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2022.v04i06.1069 · Cited by 1
Cardiovascular factors in dementia
Bidzan, L. (2022) · Psychiatria Polska · doi:10.12740/pp/150052 · Cited by 1
Stress und optimales Altern
Gogol, M. (2015) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-015-0934-8
The impact of simvastatin vs. atorvastatin on cognitive function in obese hypertensives
Зуева, И. Б., Игоревна, В. К., & Sanez, E. L. (2012) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2012-18-3-228-234
Prevention of Dementia Through Modifiable Risk Factors
Srisuwan, P. (2015) · Wiley eBooks · doi:10.1002/9781118840634.ch15
CNS Drug Targets in Development and Future Perspectives
Kelly, J. P. (2009) · Wiley eBooks · doi:10.1002/9780470682920.ch9
Associação entre doença cardiovascular e demência: um estudo clinicopatológico
Suemoto, C. K. (2010) · doi:10.11606/t.5.2010.tde-12032010-134003
Primary Prevention of Dementia
Quinn, J. G. (2013) · doi:10.1002/9781118656082.ch12
Drug Research in Older Patients
Edwards, L. D. (2010) · doi:10.1002/9781444325263.ch16
Prévention cardiovasculaire des démences
Monsuez, J.-J., & Gesquière‐Dando, A. (2010) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/s1261-694x(10)70108-5
Statins and dementia: Does length of statins use matter?
Ikewaki, K. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.055
Exposure to statins in early old age but not in late old age may be associated with a lower risk of developing Alzheimer's disease
Rosenberg, P. B. (2011) · Evidence-Based Mental Health · doi:10.1136/ebmh.14.1.14
Serum lipids and gender affect trajectories of cognitive function in late life
Wellington, C. L. (2010) · Clinical Lipidology · doi:10.2217/clp.10.46
Utilidad de los fármacos en la demencia
Moneo, M. J. G. (2010) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(10)70126-2
Type 2 Diabetes and Dementia
Strachan, M. W. J. (2011) · Springer eBooks · doi:10.1007/978-0-85729-461-6_2
Brain Amyloidosis and Triglycerides: Preventing Alzheimer Disease Pathology by Treating Vascular Disease?
Cohen, A. D., & Aizenstein, H. J. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.04.007
Nuggets of Knowledge: Statins and memory loss
Bryant, L. J. M. (2012) · Journal of Primary Health Care · doi:10.1071/hc12253
Approaches for preventive psychiatry in the geriatric population
Jhirwal, O., & Khanna, A. (2017) · Indian Journal of Social Psychiatry · doi:10.4103/ijsp.ijsp_39_17
Cardiovascular and Retinal Vascular Changes in Preclinical Alzheimer's Disease
Santos, C. (2018) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-santos-claudia-2018
Associação entre fatores de risco cardiovasculares e demência vascular definitiva
da Silva, M. M. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.7.2018.tde-05112018-151715
Alzheimer's Disease
Hort, J., O'Brien, J. T., Gainotti, G., Pirttilä, T., Popescu, B. O., Rektorová, I., Sorbi, S., & Scheltens, P. (2010) · Wiley eBooks · doi:10.1002/9781444328394.ch16
Prevention of Cognitive Decline
Lugavere, M., Seifan, A., & Isaacson, R. (2019) · Clinical handbooks in neuropsychology · doi:10.1007/978-3-319-93497-6_14
Demanstan korunma
Taşar, P. T. (2015) · Ege Tıp Dergisi · doi:10.19161/etd.344149
Literaturverzeichnis
(2015) · Elsevier eBooks · doi:10.1016/b978-3-437-31618-0.16001-8
Research, Developments and Media Coverage
Psychiatry, N. C. C. I. O. A., newspaper, F. C. Q. E. G. A. F. D. E. O. P. N. A. E. D. O. G., & Psychiatry, D. E. C. I. O. A. (2013) · doi:10.1002/9781118352335.ch9
Longitudinal associations between use of cardiovascular medications and cognitive function in three longitudinal studies of aging in SwedenPreprint
Huda, N. N. (2023) · Thesis Commons (OSF Preprints) · doi:10.31237/osf.io/2tjwz
Statins’ Effects on Alzheimer’s Disease
Li, Q., Li, C.-N., & Chen, J. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1001286 · Cited by 1
Old Age Psychiatry
FRCP, C. G. N. M., & FRCP, K. J. W. M. (2012) · doi:10.1002/9781394321995.ch4
Alzheimer's disease: Pharmacological approaches
ZEIDAN, H. M., & ZEIDAN, I. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21632-9.00006-6
Statines et paludisme
Dormoi, J. (2013) · doi:10.70675/13e18b21z6d6ez48a8zb572z334611b8fa80
The Impact of Diabetes in Older Adults
Barzilay, J. I. (2012) · Springer eBooks · doi:10.1007/978-94-007-5061-6_26 · Cited by 1

Authors: McGuinness, B., Craig, D., Bullock, R., & Passmore, P.
Affiliations: Queen's University Belfast (GB)
Victoria Hospital (CA)
ORCID: McGuinness, Bernadette
Craig, David
Passmore, Peter
Venue: Cochrane Database of Systematic Reviews
Publisher: John Wiley & Sons, Ltd
Published: 2009-04-15
Issue: 2
Pages: CD003160-CD003160
ISSN: 1361-6137 (ISSN-L)
DOI: 10.1002/14651858.cd003160.pub2
OpenAlex: W4210956788
Cited by: 193
References: 105
Citations by year: 2025: 3 · 2024: 4 · 2023: 6 · 2022: 8 · 2021: 1 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 9 · 2016: 17 · 2015: 18 · 2014: 17 · 2013: 18 · 2012: 22
Type: reference entry
Language: en
Update notices: new_version (2016-01-04)
Open access: closed
Locations: Cochrane Database of Systematic Reviews (publishedVersion)
PubMed (publishedVersion)
Research Portal (Queen's University Belfast) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: statins, dementia prevention, Alzheimer's disease, simvastatin, pravastatin, cognitive function, LDL cholesterol lowering, adverse effects, statin safety, older adults, hypercholesterolemia, dementia incidence, cholesterol-lowering drugs
MeSH terms: Alzheimer Disease, Anticholesteremic Agents, Cognition, Dementia, Humans, Randomized Controlled Trials as Topic, Pravastatin, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Simvastatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Statins for the prevention of dementia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks